{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T01:49:55Z","timestamp":1780969795513,"version":"3.54.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"crossref","award":["101136728"],"award-info":[{"award-number":["101136728"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"crossref","award":["101136728"],"award-info":[{"award-number":["101136728"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"crossref","award":["101136728"],"award-info":[{"award-number":["101136728"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"crossref","award":["101136728"],"award-info":[{"award-number":["101136728"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"name":"UNCE","award":["UNCE\/24\/MED\/008"],"award-info":[{"award-number":["UNCE\/24\/MED\/008"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Transthyretin is a tetrameric transport protein whose monomers, when destabilized, can misfold and form amyloid fibrils, leading to serious diseases like transthyretin amyloidosis cardiomyopathy and neuropathy. While kinetic stabilisers such as tafamidis or acoramidis are designed to prevent tetramer dissociation, clinical data show a puzzling increase in TTR levels after treatment\u2014an effect that our study seeks to investigate by exploring possible underlying mechanisms. Using a simple phenomenological model, we explore whether reduced dissociation alone accounts for this rise or if other mechanisms contribute. We propose that stabilisers may alter TTR clearance by slowing its cellular internalisation or degradation, or even by influencing its synthesis through pharmacological chaperoning. We also examine the role of monomer removal from circulation via re-association into tetramers or through other, possibly pathogenic processes. By integrating pharmacokinetic and pharmacodynamic data with experimental observations, our model provides fresh insights into TTR homeostasis and offers testable predictions for future research. This study highlights the power of simplified, hypothesis-driven models in uncovering biological mechanisms\u2014or, at the very least, in identifying key questions that remain to be answered.<\/jats:p>","DOI":"10.1038\/s41598-026-35000-y","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T10:54:14Z","timestamp":1767956054000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Phenomenological model of transthyretin stabilization"],"prefix":"10.1038","volume":"16","author":[{"given":"Bartek","family":"Lisowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seweryn","family":"Ulaszek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Wi\u015bniowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Bernhauerov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Polak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"issue":"4047","key":"35000_CR1","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1126\/science.177.4047.393","volume":"177","author":"PW Anderson","year":"1972","unstructured":"Anderson, P. W. More is different. Science 177(4047), 393\u2013396. https:\/\/doi.org\/10.1126\/science.177.4047.393 (1972).","journal-title":"Science"},{"key":"35000_CR2","doi-asserted-by":"crossref","unstructured":"R. Phillips, \u2018ll Seeing with an extra sense\u2019, 2024.","DOI":"10.1016\/j.cub.2024.07.003"},{"issue":"6","key":"35000_CR3","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.cels.2021.05.013","volume":"12","author":"R Phillips","year":"2021","unstructured":"Phillips, R. Schr\u00f6dinger\u2019s What Is Life? at 75. Cell Syst. 12(6), 465\u2013476. https:\/\/doi.org\/10.1016\/j.cels.2021.05.013 (2021).","journal-title":"Cell Syst."},{"key":"35000_CR4","doi-asserted-by":"publisher","unstructured":"C. Sanguinetti et al., \u2018The Journey of Human Transthyretin: Synthesis, Structure Stability, and Catabolism\u2019, 2022, MDPI. https:\/\/doi.org\/10.3390\/biomedicines10081906.","DOI":"10.3390\/biomedicines10081906"},{"issue":"47","key":"35000_CR5","doi-asserted-by":"publisher","first-page":"17020","DOI":"10.1073\/pnas.0503219102","volume":"102","author":"E Refai","year":"2005","unstructured":"Refai, E. et al. Transthyretin constitutes a functional component in pancreatic \u03b2-cell stimulus-secretion coupling. Proc. Natl. Acad. Sci. 102(47), 17020\u201317025. https:\/\/doi.org\/10.1073\/pnas.0503219102 (2005).","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"35000_CR6","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1210\/jcem-71-4-875","volume":"71","author":"B Jacobsson","year":"1990","unstructured":"Jacobsson, B., Carlstr\u00f6m, A., Platz, A. & Collins, V. P. Transthyretin messenger ribonucleic acid expression in the pancreas and in endocrine tumors of the pancreas and gut*. J. Clin. Endocrinol. Metab. 71(4), 875\u2013880. https:\/\/doi.org\/10.1210\/jcem-71-4-875 (1990).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"35000_CR7","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1007\/PL00000791","volume":"58","author":"JA Hamilton","year":"2001","unstructured":"Hamilton, J. A. & Benson, M. D. Transthyretin: A review from a structural perspective. Cell. Mol. Life Sci. 58(10), 1491\u20131521. https:\/\/doi.org\/10.1007\/PL00000791 (2001).","journal-title":"Cell. Mol. Life Sci."},{"issue":"47","key":"35000_CR8","doi-asserted-by":"publisher","first-page":"15525","DOI":"10.1021\/bi051608t","volume":"44","author":"TR Foss","year":"2005","unstructured":"Foss, T. R., Wiseman, R. L. & Kelly, J. W. The pathway by which the tetrameric protein transthyretin dissociates. Biochemistry 44(47), 15525\u201315533. https:\/\/doi.org\/10.1021\/bi051608t (2005).","journal-title":"Biochemistry"},{"key":"35000_CR9","doi-asserted-by":"publisher","unstructured":"F. Schneider and J. W. Kelly, \u2018Transthyretin slowly exchanges subunits under physiological conditions: A convenient chromatographic method to study subunit exchange in oligomeric proteins\u2019, 2001, https:\/\/doi.org\/10.1101\/ps.8901.","DOI":"10.1101\/ps.8901"},{"key":"35000_CR10","doi-asserted-by":"publisher","unstructured":"P. Hammarstr\u00f6m, \u2018The Transthyretin Protein and Amyloidosis\u2014an Extraordinary Chemical Biology Platform, 2024, John Wiley and Sons Inc. https:\/\/doi.org\/10.1002\/ijch.202300164.","DOI":"10.1002\/ijch.202300164"},{"issue":"36","key":"35000_CR11","doi-asserted-by":"publisher","first-page":"8654","DOI":"10.1021\/bi00151a036","volume":"31","author":"W Colon","year":"1992","unstructured":"Colon, W. & Kelly, J. W. Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro. Biochemistry 31(36), 8654\u20138660. https:\/\/doi.org\/10.1021\/bi00151a036 (1992).","journal-title":"Biochemistry"},{"issue":"29","key":"35000_CR12","doi-asserted-by":"publisher","first-page":"27207","DOI":"10.1074\/jbc.M101024200","volume":"276","author":"A Quintas","year":"2001","unstructured":"Quintas, A., Vaz, D. C., Cardoso, I., Saraiva, M. J. M. & Brito, R. M. M. Tetramer dissociation and monomer partial unfolding precedes protofibril formation in amyloidogenic transthyretin variants. J. Biol. Chem. 276(29), 27207\u201327213. https:\/\/doi.org\/10.1074\/jbc.M101024200 (2001).","journal-title":"J. Biol. Chem."},{"key":"35000_CR13","doi-asserted-by":"publisher","unstructured":"F. L. Ruberg, M. Grogan, M. Hanna, J. W. Kelly, and M. S. Maurer, \u2018Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review\u2019, 2019, Elsevier USA. https:\/\/doi.org\/10.1016\/j.jacc.2019.04.003.","DOI":"10.1016\/j.jacc.2019.04.003"},{"key":"35000_CR14","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.0442","author":"FL Ruberg","year":"2024","unstructured":"Ruberg, F. L. & Maurer, M. S. Cardiac amyloidosis due to transthyretin protein. Am. Med. Assoc. https:\/\/doi.org\/10.1001\/jama.2024.0442 (2024).","journal-title":"Am. Med. Assoc."},{"issue":"11","key":"35000_CR15","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.33963\/v.kp.97648","volume":"81","author":"J Grzybowski","year":"2023","unstructured":"Grzybowski, J. et al. Diagnosis and treatment of transthyretin amyloidosis cardiomyopathy: A position statement of the polish cardiac society. Kardiol. Pol. 81(11), 1167\u20131185. https:\/\/doi.org\/10.33963\/v.kp.97648 (2023).","journal-title":"Kardiol. Pol."},{"key":"35000_CR16","doi-asserted-by":"publisher","unstructured":"D. Adams, H. Koike, M. Slama, and T. Coelho, \u2018Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease\u2019, 2019, Nature Publishing Group. https:\/\/doi.org\/10.1038\/s41582-019-0210-4.","DOI":"10.1038\/s41582-019-0210-4"},{"issue":"2","key":"35000_CR17","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1056\/nejmoa2305434","volume":"390","author":"JD Gillmore","year":"2024","unstructured":"Gillmore, J. D. et al. Efficacy and safety of acoramidis in transthyretin amyloid cardiomyopathy. N. Engl. J. Med. 390(2), 132\u2013142. https:\/\/doi.org\/10.1056\/nejmoa2305434 (2024).","journal-title":"N. Engl. J. Med."},{"issue":"24","key":"35000_CR18","doi-asserted-by":"publisher","first-page":"9629","DOI":"10.1073\/pnas.1121005109","volume":"109","author":"CE Bulawa","year":"2012","unstructured":"Bulawa, C. E. et al. Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade. Proc. Natl. Acad. Sci. 109(24), 9629\u20139634. https:\/\/doi.org\/10.1073\/pnas.1121005109 (2012).","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"35000_CR19","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1080\/13506129.2020.1808783","volume":"28","author":"LT Nelson","year":"2021","unstructured":"Nelson, L. T. et al. Blinded potency comparison of transthyretin kinetic stabilisers by subunit exchange in human plasma. Amyloid 28(1), 24\u201329. https:\/\/doi.org\/10.1080\/13506129.2020.1808783 (2021).","journal-title":"Amyloid"},{"issue":"2","key":"35000_CR20","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1080\/13506129.2022.2145876","volume":"30","author":"DA Tess","year":"2023","unstructured":"Tess, D. A. et al. Relationship of binding-site occupancy, transthyretin stabilisation and disease modification in patients with tafamidis-treated transthyretin amyloid cardiomyopathy. Amyloid 30(2), 208\u2013219. https:\/\/doi.org\/10.1080\/13506129.2022.2145876 (2023).","journal-title":"Amyloid"},{"key":"35000_CR21","doi-asserted-by":"publisher","unstructured":"S. E. Saith et al., \u2018Factors associated with changes in serum transthyretin after treatment with tafamidis and outcomes in transthyretin cardiac amyloidosis\u2019, 2021, Taylor and Francis Ltd. https:\/\/doi.org\/10.1080\/13506129.2021.1904390.","DOI":"10.1080\/13506129.2021.1904390"},{"issue":"4","key":"35000_CR22","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.jaccao.2021.08.007","volume":"3","author":"RH Falk","year":"2021","unstructured":"Falk, R. H., Haddad, M., Walker, C. R., Dorbala, S. & Cuddy, S. A. M. Effect of tafamidis on serum transthyretin levels in non-trial patients with transthyretin amyloid cardiomyopathy. JACC CardioOncol. 3(4), 580\u2013586. https:\/\/doi.org\/10.1016\/j.jaccao.2021.08.007 (2021).","journal-title":"JACC CardioOncol."},{"issue":"4","key":"35000_CR23","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1080\/13506129.2024.2401154","volume":"31","author":"S Ulaszek","year":"2024","unstructured":"Ulaszek, S., Wi\u015bniowska, B. & Lisowski, B. No body fits in the test tube\u2014The case of transthyretin. Amyloid 31(4), 347\u2013349. https:\/\/doi.org\/10.1080\/13506129.2024.2401154 (2024).","journal-title":"Amyloid"},{"key":"35000_CR24","doi-asserted-by":"publisher","unstructured":"E. T. Powers, L. Amass, L. Baylor, I. Fern\u00e1ndez-Arias, S. Riley, and J. W. Kelly, \u2018Transthyretin Kinetic Stabilizers for ATTR Amyloidosis: A Narrative Review of Mechanisms and Therapeutic Benefits\u2019, 2025, Adis. https:\/\/doi.org\/10.1007\/s40119-025-00423-7.","DOI":"10.1007\/s40119-025-00423-7"},{"issue":"3685","key":"35000_CR25","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1126\/science.149.3685.748","volume":"149","author":"JH Oppenheimer","year":"1965","unstructured":"Oppenheimer, J. H., Surks, M. I., Bernstein, G. & Smith, J. C. Metabolism of Iodine-131-labeled thyroxine-binding prealbumin in man. Science 149(3685), 748\u2013751. https:\/\/doi.org\/10.1126\/science.149.3685.748 (1965).","journal-title":"Science"},{"issue":"25","key":"35000_CR26","doi-asserted-by":"publisher","first-page":"9265","DOI":"10.1021\/bi050352o","volume":"44","author":"RL Wiseman","year":"2005","unstructured":"Wiseman, R. L., Green, N. S. & Kelly, J. W. Kinetic stabilization of an oligomeric protein under physiological conditions demonstrated by a lack of subunit exchange: Implications for transthyretin amyloidosis. Biochemistry 44(25), 9265\u20139274. https:\/\/doi.org\/10.1021\/bi050352o (2005).","journal-title":"Biochemistry"},{"issue":"4","key":"35000_CR27","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3109\/13506120108993822","volume":"8","author":"Y Sekijima","year":"2001","unstructured":"Sekijima, Y. et al. Serum transthyretin monomer in patients with familial amyloid polyneuropathy. Amyloid 8(4), 257\u2013262. https:\/\/doi.org\/10.3109\/13506120108993822 (2001).","journal-title":"Amyloid"},{"issue":"12","key":"35000_CR28","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1021\/bi500171j","volume":"53","author":"I Rappley","year":"2014","unstructured":"Rappley, I. et al. Quantification of transthyretin kinetic stability in human plasma using subunit exchange. Biochemistry 53(12), 1993\u20132006. https:\/\/doi.org\/10.1021\/bi500171j (2014).","journal-title":"Biochemistry"},{"issue":"7","key":"35000_CR29","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1002\/cpdd.789","volume":"9","author":"PA Lockwood","year":"2020","unstructured":"Lockwood, P. A. et al. The bioequivalence of Tafamidis 61-mg free acid capsules and Tafamidis Meglumine 4 \u00d7 20-mg capsules in healthy volunteers. Clin. Pharmacol. Drug. Dev. 9(7), 849\u2013854. https:\/\/doi.org\/10.1002\/cpdd.789 (2020).","journal-title":"Clin. Pharmacol. Drug. Dev."},{"issue":"2","key":"35000_CR30","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1152\/jappl.1962.17.2.195","volume":"17","author":"MJ Yiengst","year":"1962","unstructured":"Yiengst, M. J. & Shock, N. W. Blood and plasma volume in adult males. J. Appl. Physiol. 17(2), 195\u2013198. https:\/\/doi.org\/10.1152\/jappl.1962.17.2.195 (1962).","journal-title":"J. Appl. Physiol."},{"key":"35000_CR31","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v033.i03","author":"K Soetaert","year":"2010","unstructured":"Soetaert, K. & Petzoldt, T. Inverse modelling, sensitivity and Monte Carlo analysis in R using package FME. J. Stat. Softw. https:\/\/doi.org\/10.18637\/jss.v033.i03 (2010).","journal-title":"J. Stat. Softw."},{"key":"35000_CR32","unstructured":"F. Marin, A. Rohatgi, and S. Charlot, \u2018WebPlotDigitizer, a polyvalent and free software to extract spectra from old astronomical publications: application to ultraviolet spectropolarimetry\u2019, Aug. 2017, [Online]. Available: http:\/\/arxiv.org\/abs\/1708.02025"},{"key":"35000_CR33","unstructured":"Committee for Medicinal Products for Human Use (CHMP), \u2018Assessment report - Vyndaquel\u2019, Sep. 2011. Accessed: Feb. 12, 2025. [Online]. Available: https:\/\/www.ema.europa.eu\/en\/documents\/assessment-report\/vyndaqel-epar-public-assessment-report_en.pdf"},{"issue":"10","key":"35000_CR34","doi-asserted-by":"publisher","first-page":"5566","DOI":"10.1073\/pnas.091431798","volume":"98","author":"HE Purkey","year":"2001","unstructured":"Purkey, H. E., Dorrell, M. I. & Kelly, J. W. \u2018Evaluating the binding selectivity of transthyretin amyloid fibril inhibitors in blood plasma. Proc Natl Acad Sci U S A 98(10), 5566\u20135571. https:\/\/doi.org\/10.1073\/pnas.091431798 (2001).","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"35000_CR35","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1074\/jbc.270.2.866","volume":"270","author":"S Wei","year":"1995","unstructured":"Wei, S. et al. Studies on the metabolism of retinol and retinol-binding protein in transthyretin-deficient mice produced by homologous recombination. J. Biol. Chem. 270(2), 866\u2013870. https:\/\/doi.org\/10.1074\/jbc.270.2.866 (1995).","journal-title":"J. Biol. Chem."},{"issue":"5213","key":"35000_CR36","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1126\/science.7754382","volume":"268","author":"H Monaco","year":"1995","unstructured":"Monaco, H., Rizzi, M. & Coda, A. Structure of a complex of two plasma proteins: transthyretin and retinol-binding protein. Science 268(5213), 1039\u20131041. https:\/\/doi.org\/10.1126\/science.7754382 (1995).","journal-title":"Science"},{"issue":"12","key":"35000_CR37","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1021\/cb100144v","volume":"5","author":"S-J Hyung","year":"2010","unstructured":"Hyung, S.-J., Deroo, S. & Robinson, C. V. Retinol and retinol-binding protein stabilize transthyretin via formation of retinol transport complex. ACS Chem. Biol. 5(12), 1137\u20131146. https:\/\/doi.org\/10.1021\/cb100144v (2010).","journal-title":"ACS Chem. Biol."},{"issue":"1","key":"35000_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbapap.2004.09.023","volume":"1703","author":"P Raghu","year":"2004","unstructured":"Raghu, P. & Sivakumar, B. Interactions amongst plasma retinol-binding protein, transthyretin and their ligands: implications in vitamin A homeostasis and transthyretin amyloidosis. Biochimica et Biophysica Acta BBA Proteins and Proteomics 1703(1), 1\u20139. https:\/\/doi.org\/10.1016\/j.bbapap.2004.09.023 (2004).","journal-title":"Biochimica et Biophysica Acta BBA Proteins and Proteomics"},{"key":"35000_CR39","doi-asserted-by":"publisher","unstructured":"M. Alhamadsheh, \u2018Comment to \u201cNelson LT, Paxman RJ, Xu J, et al. Blinded potency comparison of transthyretin kinetic stabilisers by subunit exchange in human plasma\u201d\u2019, 2021, Taylor and Francis Ltd. https:\/\/doi.org\/10.1080\/13506129.2020.1853093.","DOI":"10.1080\/13506129.2020.1853093"},{"key":"35000_CR40","doi-asserted-by":"publisher","unstructured":"J. Kelly and E. Powers, \u2018Response\u2019, 2021, Taylor and Francis Ltd. https:\/\/doi.org\/10.1080\/13506129.2020.1853094.","DOI":"10.1080\/13506129.2020.1853094"},{"issue":"6510","key":"35000_CR41","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/373123a0","volume":"373","author":"DD Ho","year":"1995","unstructured":"Ho, D. D. et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373(6510), 123\u2013126. https:\/\/doi.org\/10.1038\/373123a0 (1995).","journal-title":"Nature"},{"issue":"6510","key":"35000_CR42","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/373117a0","volume":"373","author":"X Wei","year":"1995","unstructured":"Wei, X. et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373(6510), 117\u2013122. https:\/\/doi.org\/10.1038\/373117a0 (1995).","journal-title":"Nature"},{"key":"35000_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.108031","author":"SW Jayaweera","year":"2025","unstructured":"Jayaweera, S. W. et al. Misfolding of transthyretin in vivo is controlled by the redox environment and macromolecular crowding. J. Biol. Chem. https:\/\/doi.org\/10.1016\/j.jbc.2024.108031 (2025).","journal-title":"J. Biol. Chem."},{"key":"35000_CR44","doi-asserted-by":"publisher","DOI":"10.1007\/s12575-009-9008-x","author":"HP Erickson","year":"2009","unstructured":"Erickson, H. P. \u2018Size and shape of protein molecules at the nanometer level determined by sedimentation, gel filtration, and electron microscopy. Biol. Proced. Online. https:\/\/doi.org\/10.1007\/s12575-009-9008-x (2009).","journal-title":"Biol. Proced. Online."},{"issue":"9","key":"35000_CR45","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.jacbts.2024.05.013","volume":"9","author":"R Pedretti","year":"2024","unstructured":"Pedretti, R. et al. Structure-based probe reveals the presence of large transthyretin aggregates in plasma of ATTR amyloidosis patients. JACC Basic Transl. Sci. 9(9), 1088\u20131100. https:\/\/doi.org\/10.1016\/j.jacbts.2024.05.013 (2024).","journal-title":"JACC Basic Transl. Sci."},{"issue":"7362","key":"35000_CR46","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nature10324","volume":"477","author":"T Bartels","year":"2011","unstructured":"Bartels, T., Choi, J. G. & Selkoe, D. J. \u03b1-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation. Nature 477(7362), 107\u2013111. https:\/\/doi.org\/10.1038\/nature10324 (2011).","journal-title":"Nature"},{"key":"35000_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43443-4","author":"T Sakai","year":"2023","unstructured":"Sakai, T. et al. Structural and thermodynamic insights into antibody light chain tetramer formation through 3D domain swapping. Nat. Commun. https:\/\/doi.org\/10.1038\/s41467-023-43443-4 (2023).","journal-title":"Nat. Commun."},{"issue":"18","key":"35000_CR48","doi-asserted-by":"publisher","first-page":"4661","DOI":"10.1073\/pnas.1800187115","volume":"115","author":"C Zhu","year":"2018","unstructured":"Zhu, C., Beck, M. V., Griffith, J. D., Deshmukh, M. & Dokholyan, N. V. Large SOD1 aggregates, unlike trimeric SOD1, do not impact cell viability in a model of amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U S A 115(18), 4661\u20134665. https:\/\/doi.org\/10.1073\/pnas.1800187115 (2018).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"35000_CR49","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202309217","author":"F Torricella","year":"2024","unstructured":"Torricella, F., Tugarinov, V. & Clore, G. M. Nucleation of huntingtin aggregation proceeds via conformational conversion of pre-formed, sparsely-populated tetramers. Adv. Sci. https:\/\/doi.org\/10.1002\/advs.202309217 (2024).","journal-title":"Adv. Sci."},{"key":"35000_CR50","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.117.004000","author":"JLS Hanson","year":"2018","unstructured":"Hanson, J. L. S. et al. Use of serum transthyretin as a prognostic indicator and predictor of outcome in cardiac amyloid disease associated with wild-type transthyretin. Circ. Heart Fail https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.117.004000 (2018).","journal-title":"Circ. Heart Fail"},{"issue":"5","key":"35000_CR51","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/s11897-022-00570-1","volume":"19","author":"CJ Hood","year":"2022","unstructured":"Hood, C. J. et al. Update on disease-specific biomarkers in transthyretin cardiac amyloidosis. Curr. Heart Fail Rep. 19(5), 356\u2013363. https:\/\/doi.org\/10.1007\/s11897-022-00570-1 (2022).","journal-title":"Curr. Heart Fail Rep."},{"key":"35000_CR52","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae811","author":"E Gonzalez-Lopez","year":"2025","unstructured":"Gonzalez-Lopez, E., Maurer, M. S. & Garcia-Pavia, P. Transthyretin amyloid cardiomyopathy: A paradigm for advancing precision medicine. Eur. Heart J. https:\/\/doi.org\/10.1093\/eurheartj\/ehae811 (2025).","journal-title":"Eur. Heart J."},{"issue":"1","key":"35000_CR53","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s40120-024-00696-5","volume":"14","author":"V Guglielmino","year":"2025","unstructured":"Guglielmino, V. et al. Serum biomarkers in transthyretin amyloidosis: An overview of neurofilaments, cardiac, renal, and gastrointestinal involvement. Neurol. Ther. 14(1), 71\u201384. https:\/\/doi.org\/10.1007\/s40120-024-00696-5 (2025).","journal-title":"Neurol. Ther."},{"issue":"1","key":"35000_CR54","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1186\/s13023-021-01960-9","volume":"16","author":"D Adams","year":"2021","unstructured":"Adams, D. et al. Expert opinion on monitoring symptomatic hereditary transthyretin-mediated amyloidosis and assessment of disease progression. Orphanet. J. Rare Dis. 16(1), 411. https:\/\/doi.org\/10.1186\/s13023-021-01960-9 (2021).","journal-title":"Orphanet. J. Rare Dis."},{"issue":"2","key":"35000_CR55","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1006\/bbrc.1995.1820","volume":"211","author":"Y Ando","year":"1995","unstructured":"Ando, Y. et al. Change in variant transthyretin levels in patients with familial amyloidotic polyneuropathy type I following liver transplantation. Biochem. Biophys. Res. Commun. 211(2), 354\u2013358. https:\/\/doi.org\/10.1006\/bbrc.1995.1820 (1995).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"35000_CR56","doi-asserted-by":"publisher","unstructured":"M. M. Sousa and M. J. Saraiva, \u2018Internalization of transthyretin. Evidence of a novel yet unidentified receptor-associated protein (RAP)-sensitive receptor\u2019, In: Journal of Biological Chemistry, American Society for Biochemistry and Molecular Biology Inc., Apr. 2001, pp. 14420\u201314425. https:\/\/doi.org\/10.1074\/jbc.M010869200.","DOI":"10.1074\/jbc.M010869200"},{"issue":"17","key":"35000_CR57","doi-asserted-by":"publisher","first-page":"8274","DOI":"10.1021\/acs.jmedchem.9b01037","volume":"62","author":"A Corazza","year":"2019","unstructured":"Corazza, A. et al. Binding of monovalent and bivalent ligands by transthyretin causes different short- and long-distance conformational changes. J. Med. Chem. 62(17), 8274\u20138283. https:\/\/doi.org\/10.1021\/acs.jmedchem.9b01037 (2019).","journal-title":"J. Med. Chem."},{"key":"35000_CR58","doi-asserted-by":"publisher","unstructured":"B. Basanta et al., \u2018The conformational landscape of human transthyretin revealed by cryo-EM\u2019, 2024. https:\/\/doi.org\/10.1101\/2024.01.23.576879.","DOI":"10.1101\/2024.01.23.576879"},{"key":"35000_CR59","doi-asserted-by":"publisher","unstructured":"I. C. Romine and R. L. Wiseman, \u2018Starting at the beginning: Endoplasmic reticulum proteostasis and systemic amyloid disease\u2019, 2020, Portland Press Ltd. https:\/\/doi.org\/10.1042\/BCJ20190312.","DOI":"10.1042\/BCJ20190312"},{"issue":"1","key":"35000_CR60","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.cell.2005.01.018","volume":"121","author":"Y Sekijima","year":"2005","unstructured":"Sekijima, Y. et al. The biological and chemical basis for tissue-selective amyloid disease. Cell 121(1), 73\u201385. https:\/\/doi.org\/10.1016\/j.cell.2005.01.018 (2005).","journal-title":"Cell"},{"issue":"17","key":"35000_CR61","doi-asserted-by":"publisher","first-page":"7862","DOI":"10.1021\/acs.jmedchem.8b00817","volume":"61","author":"M Miller","year":"2018","unstructured":"Miller, M. et al. Enthalpy-driven stabilization of transthyretin by AG10 mimics a naturally occurring genetic variant that protects from transthyretin amyloidosis. J. Med. Chem. 61(17), 7862\u20137876. https:\/\/doi.org\/10.1021\/acs.jmedchem.8b00817 (2018).","journal-title":"J. Med. Chem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35000-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35000-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35000-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T13:38:56Z","timestamp":1774445936000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35000-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["35000"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-35000-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]},"assertion":[{"value":"13 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this Article was revised: In the original version of this Article the License was incorrect. The License now reads \u201cCC BY\u201d.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4904"}}